Active, not recruiting
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
NCT04043195
- Conditions
- Advanced NSCLC
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States